Skip to main content
. 2019 Sep 25;10:1105. doi: 10.3389/fphar.2019.01105

Figure 2.

Figure 2

Effects of GBH on hUtMC viability. (A) Cell viability evaluated by MTT assay in hUtMCs treated with various concentrations (0–1000 μg/ml) of GBH for 24 h. (B) MTT assay after GBH treatment for 24, 48, and 72 h. The upper panel shows images obtained under light microscopy, and the lower panel shows the cell number measurements. Data are expressed as percentages of the basal value (mean ± SEM). ***P < 0.001, vs control. GBH, Gyejibongnyeong-hwan; U, ulipristal acetate; hUtMCs, human uterine myoma cells.